Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Sales | 433 | 1,508 | 0 | 634 | 257 |
| Gross Profit | 433 | 1,508 | N/A | 634 | 257 |
| Operating Expenses | 25,635 | 15,208 | 0 | 8,025 | 3,954 |
| Operating Income | -25,202 | -13,700 | N/A | -7,391 | -3,697 |
| Pre-tax Income | -25,202 | -13,700 | 0 | -7,391 | -3,697 |
| Net Income Continuous | -25,202 | -13,700 | N/A | -7,391 | -3,697 |
| Net Income | $-25,202 | $-13,700 | $N/A | $-7,391 | $-3,697 |
| EPS Basic Total Ops | -7.54 | -4.36 | N/A | -3.08 | -2.88 |
| EPS Basic Continuous Ops | -7.54 | -4.38 | N/A | -3.06 | -2.89 |
| EPS Diluted Total Ops | -7.54 | -4.36 | N/A | -3.08 | -2.88 |
| EPS Diluted Continuous Ops | -7.54 | -4.38 | N/A | -3.06 | -2.89 |
| EBITDA(a) | $-25,152 | $-13,666 | $N/A | $-7,384 | $-3,688 |